News Focus
News Focus
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

Re: jbog post# 10755

Sunday, 07/28/2013 10:33:42 PM

Sunday, July 28, 2013 10:33:42 PM

Post# of 20689
I previously predicted that Teva's thrice-weekly Copaxone will garner at most 15-20% of the US Copaxone market (#msg-87522151), so the UBS analyst (Marc Goodman) and I are on the same wavelength.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”